Prevalence of Developmental Disabilities and Receipt of Special Education Services among Children with an Inborn Error of Metabolism

Journal of Pediatrics

Volumn 156, Issue 3, 2010, Pages 420-426

  Powell, Kimberly ^a,b   Van Naarden Braun, Kim ^b   Singh, Rani ^c   Shapira, Stuart K ^d   Olney, Richard S ^c,d   Yeargin Allsopp, Marshalyn ^b  

^a Association of University Centers on Disabilities   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; DEVELOPMENTAL DISORDER; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; INBORN ERROR OF METABOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN SCREENING; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SPECIAL EDUCATION;

CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; EDUCATION, SPECIAL; HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; NEONATAL SCREENING;

EID: 76749121790     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.09.068     Document Type: Article

References (25)

1. American Academy Pediatrics Newborn Screening Task Force. Newborn screening: a blueprint for the future. Pediatrics 106 (2000) 386-427
2. Van Naarden Braun K., Yeargin-Allsopp M., Schendel D., and Fernhoff P. Long-term developmental outcomes of children identified through a newborn screening program with a metabolic or endocrine disorder: a population-based approach. J Pediatr 143 (2003) 236-242
3. Bhasin T., Brocksen S., Avchen R., and Van Naarden Braun K. Prevalence of four developmental disabilities among children aged 8 years-Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. Morbid Mortal Wkly Rep CDC Surveill Summ 55 (2006) 1-9
4. Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., and Murphy C. Prevalence of autism in a US metropolitan area. JAMA 289 (2003) 49-55
5. Van Naarden Braun K., Pettygrove S., Daniels J., Miller L., Nicholas J., Baio J., et al. Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. Morbid Mortal Wkly Rep CDC Surveill Summ 56 (2007) 29-40
6. Kaplan P., Mazur A., Field M., Berline J.A., Berry G.T., Heidenreich R., et al. Intellectual outcome in children with maple syrup urine disease. J Pediatr 119 (1991) 46-50
7. Levy H.L., Spe S.J., Walton D.S., Shih V.E., Hammersen G., Houghton S., et al. Galactose-1-phosphate uridyl transferase deficiency due to Duarte/galactosemia combined variation: clinical and biochemical studies. J Pediatr 92 (1978) 390-393
8. Schwarz H.P., Zuppinger K.A., Zimmerman A., Dauwalder H., Scherz R., and Bier D.M. Galactose intolerance in individuals with double heterozygosity for the Duarte variant and galactosemia. J Pediatr 100 (1982) 704-709
9. Waggoner D., Buist N., and Donnell G. Long-term prognosis in galactosemia: results of a survey of 350 cases. J Inherit Metab Dis 13 (1990) 802-808
10. Robertson A., Singh R.H., BGuerrero N.V., Hundley M., and Elsas L.J. Outcomes analysis of verbal dyspraxia in classic galactosemia. Genet Med 2 (2000) 142-148
11. Nelson C.D., Waggoner D.D., Donnell G.N., Tuerck J.M., and Buist N.R.M. Verbal dyspraxia in treated galactosemia. Pediatrics 88 (1991) 346-350
12. Waisbren S.E., Norman T.R., Schnell R.R., and Levy H.L. Speech and language deficits in early treated children with galactosemia. J Pediatr 102 (1983) 75-77
13. Waisbren S.E., Albers S., Amato S., Ampola M., Brewster T.G., Demmer L., et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 290 (2003) 2564-2572
14. Trevisson E., Salvianti L., Baldoin M.C., Toldo I., Casarin A., Sacconi S., et al. Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Human Mutation 28 (2007) 694-702
15. Parsons H., Scott R., Pinto A., Carter R., and Snyder F. Argininosuccinic aciduria: long-term treatment with arginine. J Inherit Metab Dis 10 (1987) 152-161
16. Widhalm K., Koch S., Scheibenreiter S., Knoll E., Colombo J., Bachmann C., et al. Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy. Pediatrics 89 (1992) 1182-1184
17. Maestri N.E., Brusilow S.W., Clissold D.B., and Bassett S.S. Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 335 (1996) 855-859
18. Maestri N., Hauser E., Bartholomew D., and Brusilow S. Prospective treatment of urea cycle disorders. J Pediatr 119 (1991) 923-928
19. Prietsch V., Mayatepek E., Krastel H., Haas D., Zundel D., Waterham H.R., et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 111 (2003) 258-261
20. Deodato F., Boenzi S., Santorelli F., and Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet Part C Semin Med Genet 142C (2006) 104-112
21. Surtees R., Matthews E., and Leonard J. Neurologic outcomes of propionic acidemia. Pediatr Neurol 8 (1992) 333-337
22. North K., Korson M., Gopal Y., Rohr F., Brazelton T., Waisbren S., et al. Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for management. J Pediatr 126 (1995) 916-922
23. van der Meer S., Poggi F., Spada M., Bonnefont J., Ogier H., Hubert P., et al. Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr 125 (1994) 903-908
24. Ogier de Baulny H., Benoist J., Rigal O., Touati G., Rabier D., and Saudubray J. Methylmalonic and propionic acidemias: management and outcome. J Inherit Metab Dis 28 (2005) 415-423
25. Georgia Department of Human Resources Division of Public Health. Atlanta; c1999-c2006. Georgia Newborn Screening Program. Available at http://health.state.ga.us/programs/nsmscd/index.asp. Accessed May 31, 2009.